Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.
“I know all the statistics — the odds are against me,” Ringen says. “You don’t actually obtain hope until you meet another individual who’s pretty much just like you — same stage, same treatment options — and they’re out four years, five years, six years, seven years.”
